| HGNC Family | Non-coding RNAs |
| Name | microRNA 135a-1 |
| Description | microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nMiR‐135a (including its 5p, 3p, and related isoforms) has emerged as a multifaceted regulator in cancer, displaying context‐dependent oncogenic or tumor‐suppressive functions. In colorectal cancer, for instance, miR‐135a targets the 3′‐UTR of the APC gene to downregulate its expression and thereby activate the Wnt/β‐catenin pathway, whereas in cervical and malignant melanoma cells it promotes proliferation and invasion via suppression of tumor‐suppressive targets such as SIAH1 and FOXO1. In breast, prostate, ovarian, gastric, non‐small cell lung, and several other cancers, restoration of miR‐135a expression dampens oncogenic drivers—including Runx2, ROCK1/2, MTSS1, HOXA10, SIRT1, E2F1/DAPK2, CCR2, and components of the MAPK and PI3K/AKT cascades—and thereby inhibits tumor cell proliferation, migration, invasion, epithelial–mesenchymal transition, and chemoresistance. In certain settings, however, its overexpression can enhance tumorigenic traits by promoting aberrant signaling through pathways such as β‐catenin activation. Collectively, these studies underscore that miR‐135a regulates multiple signaling networks in cancer, and its precise impact on tumor progression is tightly dependent on the cellular context and interacting molecular partners."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "38"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond oncogenesis, miR‐135a also plays pivotal roles in non‐neoplastic conditions by modulating key signaling pathways that govern cellular stress responses and tissue homeostasis. In models of metabolic or vascular disorders, miR‐135a represses the mineralocorticoid receptor (NR3C2) to influence blood pressure regulation and has been implicated in diabetic nephropathy. In models of lung injury, enhanced miR‐135a expression following lipopolysaccharide challenge promotes apoptosis through the downregulation of anti‐apoptotic Bcl‐2, while in mechanical stretch and ventilator‐induced injury of endothelial cells its modulation affects barrier function. Furthermore, dysregulation of miR‐135a in podocyte injury disrupts cytoskeletal organization via targeting GSK3β, and in neuropathic pain models, its sequestration by circular RNAs alters autophagy and inflammatory responses. Notably, in the context of neurodegeneration such as Alzheimer’s disease, astrocyte‐derived miR‐135a contributes to neuroinflammation and neuronal loss by impinging on thrombospondin 1 levels and related apoptotic pathways. These findings collectively highlight miR‐135a as an important molecular rheostat not only in cancer but also in a spectrum of cellular injury and repair processes."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "39", "end_ref": "46"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Remco Nagel, Carlos le Sage, Begoña Diosdado, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Regulation of the adenomatous polyposis coli gene by the miR-135 family in colorectal cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-08-0951"}], "href": "https://doi.org/10.1158/0008-5472.CAN-08-0951"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18632633"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18632633"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Hanna Taipaleenmäki, Gillian Browne, Jacqueline Akech, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Targeting of Runx2 by miR-135 and miR-203 Impairs Progression of Breast Cancer and Metastatic Bone Disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-14-1026"}], "href": "https://doi.org/10.1158/0008-5472.CAN-14-1026"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25634212"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25634212"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Shupeng Liu, Weixing Guo, Jie Shi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-135a contributes to the development of portal vein tumor thrombus by promoting metastasis in hepatocellular carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Hepatol (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jhep.2011.08.008"}], "href": "https://doi.org/10.1016/j.jhep.2011.08.008"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21888875"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21888875"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Alfons Navarro, Tania Diaz, Antonio Martinez, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Regulation of JAK2 by miR-135a: prognostic impact in classic Hodgkin lymphoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2009-02-204842"}], "href": "https://doi.org/10.1182/blood-2009-02-204842"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19666866"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19666866"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "A Kroiss, S Vincent, M Decaussin-Petrucci, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Androgen-regulated microRNA-135a decreases prostate cancer cell migration and invasion through downregulating ROCK1 and ROCK2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2014.222"}], "href": "https://doi.org/10.1038/onc.2014.222"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25065599"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25065599"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Yufei Zhou, Shaoxia Li, Jiangtao Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Physiol Biochem (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1159/000479207"}], "href": "https://doi.org/10.1159/000479207"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28715819"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28715819"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Ying Yang, Mari B Ishak Gabra, Eric A Hanse, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-135 suppresses glycolysis and promotes pancreatic cancer cell adaptation to metabolic stress by targeting phosphofructokinase-1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41467-019-08759-0"}], "href": "https://doi.org/10.1038/s41467-019-08759-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30778058"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30778058"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Hao Sun, Qingtao Meng, Chengyu Shi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Hypoxia-Inducible Exosomes Facilitate Liver-Tropic Premetastatic Niche in Colorectal Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hepatology (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/hep.32009"}], "href": "https://doi.org/10.1002/hep.32009"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34110633"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34110633"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "S Wu, Y Lin, D Xu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-135a functions as a selective killer of malignant glioma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2011.551"}], "href": "https://doi.org/10.1038/onc.2011.551"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22139076"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22139076"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Hongyang Shi, Yuqiang Ji, Dexin Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-135a inhibits migration and invasion and regulates EMT-related marker genes by targeting KLF8 in lung cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2015.07.145"}], "href": "https://doi.org/10.1016/j.bbrc.2015.07.145"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26235874"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26235874"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Weiwei Tang, Yi Jiang, Xiaoxin Mu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-135a functions as a tumor suppressor in epithelial ovarian cancer and regulates HOXA10 expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Signal (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cellsig.2014.03.002"}], "href": "https://doi.org/10.1016/j.cellsig.2014.03.002"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24607788"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24607788"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Yuanshan Yao, Qingwang Hua, Yinjie Zhou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CircRNA has_circ_0001946 promotes cell growth in lung adenocarcinoma by regulating miR-135a-5p/SIRT1 axis and activating Wnt/β-catenin signaling pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomed Pharmacother (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biopha.2018.12.120"}], "href": "https://doi.org/10.1016/j.biopha.2018.12.120"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30841451"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30841451"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Weiwei Zhou, Xiayu Li, Fen Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-135a promotes growth and invasion of colorectal cancer via metastasis suppressor 1 in vitro."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Acta Biochim Biophys Sin (Shanghai) (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/abbs/gms071"}], "href": "https://doi.org/10.1093/abbs/gms071"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23017832"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23017832"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Xiao Peng Mao, Luo Sheng Zhang, Bin Huang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mir-135a enhances cellular proliferation through post-transcriptionally regulating PHLPP2 and FOXO1 in human bladder cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Transl Med (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12967-015-0438-8"}], "href": "https://doi.org/10.1186/s12967-015-0438-8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25888950"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25888950"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Ji-Young Shin, Young-Il Kim, Soo-Jeong Cho, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA 135a suppresses lymph node metastasis through down-regulation of ROCK1 in early gastric cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0085205"}], "href": "https://doi.org/10.1371/journal.pone.0085205"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24465504"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24465504"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Jian-Wen Ren, Zhang-Jun Li, Chen Tu "}, {"type": "b", "children": [{"type": "t", "text": "MiR-135 post-transcriptionally regulates FOXO1 expression and promotes cell proliferation in human malignant melanoma cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Clin Exp Pathol (2015)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26261511"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26261511"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Carmen O N Leung, Wen Deng, Tian-Min Ye, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-135a leads to cervical cancer cell transformation through regulation of β-catenin via a SIAH1-dependent ubiquitin proteosomal pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Carcinogenesis (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/carcin/bgu032"}], "href": "https://doi.org/10.1093/carcin/bgu032"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24503442"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24503442"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Wenbin Zhou, Xingjie Bi, Guojun Gao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miRNA-133b and miRNA-135a induce apoptosis via the JAK2/STAT3 signaling pathway in human renal carcinoma cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomed Pharmacother (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biopha.2016.09.074"}], "href": "https://doi.org/10.1016/j.biopha.2016.09.074"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27710896"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27710896"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Qiong Wu, Min Shi, Wenying Meng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long noncoding RNA FOXD3-AS1 promotes colon adenocarcinoma progression and functions as a competing endogenous RNA to regulate SIRT1 by sponging miR-135a-5p."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Physiol (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcp.28752"}], "href": "https://doi.org/10.1002/jcp.28752"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31058315"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31058315"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Weiliang Jiang, Senlin Zhao, Jia Shen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The MiR-135b-BMAL1-YY1 loop disturbs pancreatic clockwork to promote tumourigenesis and chemoresistance."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41419-017-0233-y"}], "href": "https://doi.org/10.1038/s41419-017-0233-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29396463"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29396463"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Zheng Dang, Wei-Hua Xu, Peng Lu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-135a inhibits cell proliferation by targeting Bmi1 in pancreatic ductal adenocarcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Biol Sci (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.7150/ijbs.8097"}], "href": "https://doi.org/10.7150/ijbs.8097"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25013381"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25013381"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Xia-Wa Mao, Jia-Quan Xiao, Zhong-Yi Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Effects of microRNA-135a on the epithelial-mesenchymal transition, migration and invasion of bladder cancer cells by targeting GSK3β through the Wnt/β-catenin signaling pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Exp Mol Med (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/emm.2017.239"}], "href": "https://doi.org/10.1038/emm.2017.239"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29350680"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29350680"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Jie Zhou, Qing Chen "}, {"type": "b", "children": [{"type": "t", "text": "Poor expression of microRNA-135b results in the inhibition of cisplatin resistance and proliferation and induces the apoptosis of gastric cancer cells through MST1-mediated MAPK signaling pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FASEB J (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1096/fj.201800618RRR"}], "href": "https://doi.org/10.1096/fj.201800618RRR"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30576232"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30576232"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Xuechao Wan, Honglei Pu, Wenhua Huang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Androgen-induced miR-135a acts as a tumor suppressor through downregulating RBAK and MMP11, and mediates resistance to androgen deprivation therapy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.9992"}], "href": "https://doi.org/10.18632/oncotarget.9992"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27323416"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27323416"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Zhenguo Cheng, Funan Liu, Hongyan Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-135a inhibits tumor metastasis and angiogenesis by targeting FAK pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.16098"}], "href": "https://doi.org/10.18632/oncotarget.16098"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28415713"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28415713"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Shanshan Yao, Chuan Tian, Youcheng Ding, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Down-regulation of Krüppel-like factor-4 by microRNA-135a-5p promotes proliferation and metastasis in hepatocellular carcinoma by transforming growth factor-β1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.9934"}], "href": "https://doi.org/10.18632/oncotarget.9934"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27302923"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27302923"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Songhe Shen, Xiaoli Zheng, Zhixiang Zhu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Silencing of GAS5 represses the malignant progression of atherosclerosis through upregulation of miR-135a."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomed Pharmacother (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biopha.2019.109302"}], "href": "https://doi.org/10.1016/j.biopha.2019.109302"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31545249"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31545249"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Zhe Cao, Jiangdong Qiu, Gang Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-135a biogenesis and regulation in malignancy: a new hope for cancer research and therapy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Biol Med (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.20892/j.issn.2095-3941.2020.0033"}], "href": "https://doi.org/10.20892/j.issn.2095-3941.2020.0033"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32944391"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32944391"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Satoshi Fukagawa, Kohei Miyata, Fusanori Yotsumoto, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-135a-3p as a promising biomarker and nucleic acid therapeutic agent for ovarian cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Sci (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/cas.13210"}], "href": "https://doi.org/10.1111/cas.13210"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28231414"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28231414"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Bin Xu, Tao Tao, Yiduo Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "hsa-miR-135a-1 inhibits prostate cancer cell growth and migration by targeting EGFR."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Tumour Biol (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s13277-016-5196-6"}], "href": "https://doi.org/10.1007/s13277-016-5196-6"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27524492"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27524492"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Motonobu Saito, Kouya Shiraishi, Kenji Matsumoto, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A three-microRNA signature predicts responses to platinum-based doublet chemotherapy in patients with lung adenocarcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Cancer Res (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1078-0432.CCR-14-1096"}], "href": "https://doi.org/10.1158/1078-0432.CCR-14-1096"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25142144"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25142144"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Lin-Hai Yan, Zhi-Ning Chen, Li-Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-135a promotes gastric cancer progression and resistance to oxaliplatin."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.12208"}], "href": "https://doi.org/10.18632/oncotarget.12208"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27683111"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27683111"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Daniela M Gomez Zubieta, Mohamed A Hamood, Rami Beydoun, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-135a regulates NHE9 to inhibit proliferation and migration of glioblastoma cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Commun Signal (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12964-017-0209-7"}], "href": "https://doi.org/10.1186/s12964-017-0209-7"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29268774"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29268774"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Daqiong Jiang, Bo Zhou, Yan Xiong, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-135 regulated breast cancer proliferation and epithelial-mesenchymal transition acts by the Wnt/β-catenin signaling pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Mol Med (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/ijmm.2019.4081"}], "href": "https://doi.org/10.3892/ijmm.2019.4081"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30720046"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30720046"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Ying Zhang, Wan-Li Jiang, Jun-Yuan Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Downregulation of lysyl oxidase-like 4 LOXL4 by miR-135a-5p promotes lung cancer progression in vitro and in vivo."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Physiol (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcp.28508"}], "href": "https://doi.org/10.1002/jcp.28508"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30993701"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30993701"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Yonghui Wang, Zhengguang Hou, Dong Li "}, {"type": "b", "children": [{"type": "t", "text": "Long noncoding RNA UCA1 promotes anaplastic thyroid cancer cell proliferation via miR‑135a‑mediated c‑myc activation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Med Rep (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/mmr.2018.9276"}], "href": "https://doi.org/10.3892/mmr.2018.9276"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30015867"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30015867"}]}, {"type": "r", "ref": 37, "children": [{"type": "t", "text": "Yong Tang, Guojun Cao, Gang Zhao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA differentiation antagonizing non-protein coding RNA promotes proliferation and invasion through regulating miR-135a/NLRP37 axis in pancreatic cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Invest New Drugs (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s10637-019-00798-0"}], "href": "https://doi.org/10.1007/s10637-019-00798-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31267381"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31267381"}]}, {"type": "r", "ref": 38, "children": [{"type": "t", "text": "Nicolaas Van Renne, Armando Andres Roca Suarez, Francois H T Duong, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-135a-5p-mediated downregulation of protein tyrosine phosphatase receptor delta is a candidate driver of HCV-associated hepatocarcinogenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Gut (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1136/gutjnl-2016-312270"}], "href": "https://doi.org/10.1136/gutjnl-2016-312270"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28159835"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28159835"}]}, {"type": "r", "ref": 39, "children": [{"type": "t", "text": "Feng He, Fenfen Peng, Xi Xia, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-135a promotes renal fibrosis in diabetic nephropathy by regulating TRPC1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Diabetologia (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00125-014-3282-0"}], "href": "https://doi.org/10.1007/s00125-014-3282-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24908566"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24908566"}]}, {"type": "r", "ref": 40, "children": [{"type": "t", "text": "Siim Sõber, Maris Laan, Tarmo Annilo "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNAs miR-124 and miR-135a are potential regulators of the mineralocorticoid receptor gene (NR3C2) expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2009.11.128"}], "href": "https://doi.org/10.1016/j.bbrc.2009.11.128"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19944075"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19944075"}]}, {"type": "r", "ref": 41, "children": [{"type": "t", "text": "Yuanyuan Liu, Shengtao Liao, Hongyu Quan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Involvement of microRNA-135a-5p in the Protective Effects of Hydrogen Sulfide Against Parkinson's Disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Physiol Biochem (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1159/000452521"}], "href": "https://doi.org/10.1159/000452521"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27842305"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27842305"}]}, {"type": "r", "ref": 42, "children": [{"type": "t", "text": "Xianggui Yang, Xiaoyan Wang, Fang Nie, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-135 family members mediate podocyte injury through the activation of Wnt/β-catenin signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Mol Med (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/ijmm.2015.2259"}], "href": "https://doi.org/10.3892/ijmm.2015.2259"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26134897"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26134897"}]}, {"type": "r", "ref": 43, "children": [{"type": "t", "text": "Wei Cai, Yang Zhang, Zhen Su "}, {"type": "b", "children": [{"type": "t", "text": "ciRS-7 targeting miR-135a-5p promotes neuropathic pain in CCI rats via inflammation and autophagy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Gene (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.gene.2020.144386"}], "href": "https://doi.org/10.1016/j.gene.2020.144386"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31978512"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31978512"}]}, {"type": "r", "ref": 44, "children": [{"type": "t", "text": "Jing Zhao, Xu Li, Ming Zou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-135a inhibition protects A549 cells from LPS-induced apoptosis by targeting Bcl-2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2014.09.025"}], "href": "https://doi.org/10.1016/j.bbrc.2014.09.025"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25230140"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25230140"}]}, {"type": "r", "ref": 45, "children": [{"type": "t", "text": "Xiaodi Yan, Wenqian Li, Liye Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-135a Protects Vascular Endothelial Cells Against Ventilator-Induced Lung Injury by Inhibiting PHLPP2 to Activate PI3K/Akt Pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Physiol Biochem (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1159/000492010"}], "href": "https://doi.org/10.1159/000492010"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30045018"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30045018"}]}, {"type": "r", "ref": 46, "children": [{"type": "t", "text": "Yu-Yi Chu, Chiung-Yuan Ko, Wei-Jan Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Astrocytic CCAAT/Enhancer Binding Protein δ Regulates Neuronal Viability and Spatial Learning Ability via miR-135a."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Neurobiol (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s12035-015-9359-z"}], "href": "https://doi.org/10.1007/s12035-015-9359-z"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26208701"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26208701"}]}]}]}
|
| Synonyms | MIRN135A1, MIRN135-1, MIR-135A-1 |
| NCBI Gene ID | 406925 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
MIR135A1 has 307 functional associations with biological entities spanning 4 categories (molecular profile, functional term, phrase or reference, cell line, cell type or tissue, gene, protein or microRNA) extracted from 13 datasets.
Click the + buttons to view associations for MIR135A1 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR135A1 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR135A1 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of MIR135A1 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at MIR135A1 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR135A1 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of MIR135A1 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with MIR135A1 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing MIR135A1 from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of MIR135A1 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of MIR135A1 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR135A1 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of MIR135A1 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at MIR135A1 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |